The Center for the Biology of Chronic Disease
Valley Cottage, New York, 10989, United States
NCT Number: NCT02715752
This study measured the changes in health-related complaints by analyzing charts of individuals, who are infected with a latent virus, who have used Gene-Eden-VIR/Novirin.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Valley Cottage, New York, 10989, United States
The medical community calls the movement from severe to mild disease and from mild to normal health, 'relieving symptoms', and the interventions that cause such movement, drugs, medications, or therapies. The alternative community calls the movement from normal health to superior health, 'boosting health' (or boosting the immune system, or improving your sex drive, or boosting any another well functioning physiological system), and the interventions that cause such movement, natural remedies, dietary supplements, complementary treatments, etc. In general, these interventions aim to achieve superior performance of a normal human body. Of course, boosting the body's normal performance improves many of its capabilities, such as higher resistance to diseases, faster recovery from fatigue, better mental concentration, etc. Each movement presents different objectives. Relieving symptoms represents the ability of an intervention to reduce the frequency, duration, and severity of a disease. In contrast, boosting health represents the ability of an intervention to increase the frequency, duration, and quality of a person's health. In the current study, the investigators would like to measure the changes in health-related complaints by analyzing charts of individuals, who are infected with latent virus, and who have used Gene-Eden-VIR/Novirin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Time frame: one year
Time frame: one year
The Center for the Biology of Chronic Disease
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02579083
DNA Virus Infections, HIV
Providence, Rhode Island, United States
View Trial DetailsNCT02270099
DNA Virus Infections, Herpes Simplex
Birmingham, Alabama, United States
View Trial DetailsNCT01429311
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Denver, Colorado, United States
View Trial DetailsNCT04693637
Adenoviridae Infections, Adenovirus Infection
Birmingham, Alabama, United States
View Trial Details